EZH2 and neoplasm: EZH2-mediated PRC2 activation contributes to the transcriptional silencing of tumor suppressor genes, leading to the activation of NOTCH [36], JAK-STAT [37], or β-catenin signaling pathways [38] and upregulation of cell cycle genes, such as CDK2, CDK4, and CCND1.